{
    "2018-03-30": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Cool Apps For Financial Advisors",
                "features": {
                    "keywords": [
                        "financial",
                        "advisors",
                        "apps"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Better Buy: Biogen Inc. vs. Amgen Inc.",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Amgen",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Is Celgene a Beaten-Up Biotech Stock to Buy?",
                "features": {
                    "keywords": [
                        "Celgene",
                        "beaten-up",
                        "biotech",
                        "stock",
                        "buy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "WSJ: Ex-Merrill Lynch CEO Thain Expected To Join Deutsche Bank Supervisory Board",
                "features": {
                    "keywords": [
                        "Merrill Lynch",
                        "CEO",
                        "Thain",
                        "Deutsche Bank",
                        "supervisory board"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}